newsfilter
← Latest News
Business Wire·

Cortexyme to Present at Investor Conferences in June 2021

Cortexyme, Inc. (NASDAQ:CRTX), a company advancing a pivotal trial in Alzheimer's disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Chris Lowe, the company's